News | FDA | December 09, 2025

Remington Medical’s Bluetooth-Enabled, Cordless Doppler Gets FDA Clearance

The VascuCheck 2.0 handheld device adds optional external speaker for louder, clearer audio.

Remington Medical’s Bluetooth-Enabled, Cordless Doppler Gets FDA Clearance

Photo: Getty Images


Nov. 25, 2025 — Remington Medical has received U.S. Food and Drug Administration (FDA) 510(k) clearance and announced the commercial launch of the second-generation VascuChek Doppler. VascuChek is a handheld vascular Doppler device for clinical and surgical use. With the addition of a Bluetooth external speaker, VascuChek 2.0 gives clinicians and surgeons superior audio clarity and volume to more accurately assess patients’ blood flow during surgeries.

The second-generation VascuChek builds upon the first-gen device’s features with the same convenient handheld control and cordless freedom for monitoring vascular flow. The kit consists of a handheld transceiver and a detachable, disposable probe (both surgical and clinical variants). The probe attaches to the transceiver similar to how the brush head of an electric toothbrush connects with the handle.

Its single-use probes with patented antiseptic sheath make VascuChek the only wireless, handheld Doppler device that has been FDA-cleared for evaluating intraoperative and subcutaneous blood flow in a sterile field during surgery.

VascuChek has two internal speakers for real-time audio feedback when assessing a patient’s blood flow. If necessary, users can toggle the audio to the Bluetooth speaker built into the device’s charging base to provide improved clarity and volume.

“When it launched in 2022, VascuChek was a big leap forward for convenience and ease, offering surgeons a cordless Doppler that gave them full control,” said Attly Aycock, CEO of Remington Medical. “The new device builds on that and adds even better audio clarity and volume; we made these updates based on valuable feedback from surgeons who’ve been using VascuChek in their ORs. We’re confident that VascuChek can transform operational efficiencies for the more than 38,000 operating rooms across the U.S.”

Primary users of VascuChek include vascular, cardiac, orthopedic, podiatry and general surgeons, cardiologists and surgical nurses. VascuChek is currently available for sale within the U.S.

For inquiries about VascuChek, or to schedule a product demonstration, please visit https://vascuchek.com/contact/


Additional Content

News | Cath Lab

Nov. 2, 2026 — Royal Philips has announced U.S. commercial availability of the HyperVue Integrated System1, a new single ...

Home November 03, 2026
Home
News | Cath Lab

Aug. 28, 2026 — Heartflow, Inc. has announced late-breaking one-year results from an independent randomized clinical ...

Home August 28, 2026
Home
News | Cath Lab

July 9, 2026 — On July 9, Stereotaxis announced that it has completed its previously announced acquisition of Robocath ...

Home July 10, 2026
Home
News | Cath Lab

June 18, 2026 — Allegheny Health Network's (AHN) Allegheny General Hospital (AGH) has completed a $19 million renovation ...

Home June 18, 2026
Home
News | Cath Lab

May 28, 2026 — RWJBarnabas Health has earned Cardiac Catheterization Lab Accreditation from the American College of ...

Home May 29, 2026
Home
Subscribe Now